ADAR1 Capital Management »

Arya Sciences Acquisition-a shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Arya Sciences Acquisition-a (ARYD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Arya Sciences Acquisition-a

Tip: Access up to 7 years of quarterly data

All positions including Arya Sciences Acquisition-a held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arya Sciences Acquisition-a by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $460k 41k 11.23

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Arya Sciences Acquisition-a

Glazer Capital
Berkley W R
Meteora Capital
Cowen And Company
Mizuho Securities USA
Vivaldi Asset Management
Farallon Capital Management
Tenor Capital Management
Hsbc Holdings
Shaolin Capital Management
OZ Management
Exos TFP Holdings
ADAR1 Capital Management
Walleye Trading Advisors
Fir Tree

View all funds holding Arya Sciences Acquisition-a